Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Capital Expenditures (2018 - 2025)

Skinvisible's Capital Expenditures history spans 7 years, with the latest figure at -$1.0 for Q3 2025.

  • On a quarterly basis, Capital Expenditures changed N/A to -$1.0 in Q3 2025 year-over-year; TTM through Dec 2025 was -$1.0, a 0.0% change, with the full-year FY2025 number at $4086.0, down 55.67% from a year prior.
  • Capital Expenditures hit -$1.0 in Q3 2025 for Skinvisible, roughly flat from -$1.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for SKVI hit a ceiling of $20414.0 in Q2 2021 and a floor of -$1.0 in Q3 2023.
  • Historically, Capital Expenditures has averaged $4388.7 across 4 years, with a median of $525.0 in 2022.
  • The widest YoY moves for Capital Expenditures: up 47.9% in 2021, down 48.28% in 2021.
  • Tracing SKVI's Capital Expenditures over 4 years: stood at $20414.0 in 2021, then crashed by 97.43% to $525.0 in 2022, then plummeted by 100.19% to -$1.0 in 2023, then changed by 0.0% to -$1.0 in 2025.
  • Business Quant data shows Capital Expenditures for SKVI at -$1.0 in Q3 2025, -$1.0 in Q3 2023, and $8809.0 in Q2 2023.